I-Desquinolinyl Lenvatinib CAS 796848-79-8 Ubumsulwa >99.0% (HPLC) I-Lenvatinib Mesylate Intermediate Factory

Incazelo emfushane:

1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea

Amazwi afanayo: Desquinolinyl Lenvatinib

I-CAS: 796848-79-8

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Okumhlophe Okumhlophe ukuya Kokubomvu Okunsundu Okuqinile

I-Intermediate ye-Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali 1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea
Omqondofana I-Desquinolinyl Lenvatinib;I-Lenvatinib Ukungcola 16;I-Lenvatinib Desquinolinyl Ukungcola;I-Lenvatinib Ukungcola LFS-A;I-Lenvatinib Mesylate Intermediate Ⅲ;N-(2-Chloro-4-Hydroxyphenyl)-N'-Cyclopropyl-Urea
Inombolo ye-CAS 796848-79-8
Inombolo yeCAT I-RF-PI1972
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C10H11ClN2O2
Isisindo samangqamuzana 226.66
Iphuzu elibilayo 364.6±42.0℃
Ukuminyana 1.43±0.10 g/cm3
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Off-White to Reddish Brown Solid Powder
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
Umswakama (KF) <0.50%
Izinsalela ekushiseni <0.20%
Ukungcola Okukodwa <0.50%
Ukungcola Okuphelele <1.00%
Izinsimbi Ezisindayo <10ppm
I-Infrared Spectrum Ivumelana Nesakhiwo
I-NMR Ivumelana Nesakhiwo
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Lenvatinib Mesylate (CAS: 857890-39-2)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea, eyaziwa nangokuthi i-Desquinolinyl Lenvatinib, (CAS: 796848-79-8) iwukungcola okumaphakathi noma okuphakathi kwe-Lenvatinib Mesylate (CAS: 857890-39-2).I-Desquinolinyl Lenvatinib iyi-metabolite ye-Lenvatinib Mesylate eyi-inhibitor esebenzayo ngomlomo yama-multiple receptor tyrosine kinases okuhlanganisa i-VEGF, i-FGF ne-SCF receptors.I-Lenvatinib iyisidakamizwa esilwa nomdlavuza ekwelapheni izinhlobo ezithile zomdlavuza wegilo, futhi okungenzeka nakwamanye umdlavuza.NgoFebhuwari 13, 2015, i-US FDA yagunyaza isidakamizwa esilwa nomdlavuza i-Lenvatinib sokwelapha umdlavuza wegilo.I-Lenvatinib iyi-multi-target enzyme inhibitor, ekwazi ukuvimbela i-VEGFR2 ne-VEGFR3 (i-vascular endothelial growth factor receptor).Igama lokuhweba le-Lenvatinib yi-Lenvima.

Bhala umyalezo wakho lapha futhi usithumelele wona